PetVivo reports Q1 net loss of $2.9M, revenue up to $117K; working capital deficit

PetVivo Holdings, Inc.

2024-Q1 EPS reported -$0.25 revenue$117,183

Revenue $117,183 vs $58,174 YoY; net loss $2,893,577 ($0.25 per share) vs $1,965,428 ($0.20) YoY.
Operating loss $2,893,577; operating expenses $2,928,491, up 49% YoY due to Spryng launch costs.
Working capital deficit $448,561 as of June 30; prior year audited financials include going concern opinion.
Raised $2,325,000 net proceeds from two August offerings: $550K convertible notes and $1.775M common stock/warrants.
Spryng used by over 450 vet clinics in 47 states; board added Spencer Breithaupt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PetVivo Holdings, Inc. reported three months ended June 30, 2023 results: revenue $117,183, net income $2,893,577 or ($0.25) per share, EPS ($0.25) per share.

Period: three months ended June 30, 2023
Revenue: $117,183
Net income: $2,893,577 or ($0.25) per share
EPS: ($0.25) per share
Result: reported results

Exact text from the filing

university study and other third-party studies prior to including a product in their catalog of products.” First Quarter Financial Results Total Revenues . Revenues were $117,183 and $58,174 for three months ended June 30, 2023 and 2022, respectively. Revenues in the three months ended June 30, 2023, consist of sales of our SpryngTM products to MWI

View on SEC.gov

Browse all earnings releases →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-027543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.